The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE |
Rheumatology (Oxford). 2021 Dec 1;60(12):5583-5594.doi: 10.1093/rheumatology/keab158.
Vibeke Strand 1, Namita Tundia 2, Martin Bergman 3, Andrew Ostor 4, Patrick Durez 5, In-Ho Song 2, Jeffrey Enejosa 2, Casey Schlacher 2, Yan Song 6, Roy Fleischmann 7 |
| 2 | |
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis |
N Engl J Med. 2022 Jan 27;386(4):316-326.doi: 10.1056/NEJMoa2109927.
Steven R Ytterberg 1, Deepak L Bhatt 1, Ted R Mikuls 1, Gary G Koch 1, Roy Fleischmann 1, Jose L Rivas 1, Rebecca Germino 1, Sujatha Menon 1, Yanhui Sun 1, Cunshan Wang 1, Andrea B Shapiro 1, Keith S Kanik 1, Carol A Connell 1, ORAL Surveillance Investigators Collaborators ORAL Surveillance Investigators: Steven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, Gary G Koch, Alejandro Alvarellos, Analia Alvarez, Alberto Berman, Maria Correa, Rodolfo Pardo Hidalgo, Maria Lazaro, Pablo Maid, Leonardo Naftal, Bernardo Pons-Estel, Guillermo Tate, Russell Buchanan, Maureen Rischmueller, Evangelos Romas, Robert Will, Ana Paula Assad, Valderilio Feijo Azevedo, Rubens Bonfiglioli, William Chahade, Celso Ricardo de Abreu, Ricardo de Toledo, Ari Halpern, Adriana Maria Kakehasi, Flora Marcolino, Ana Claudia Melazzi, Tatiana Muller, Mittermayer Santiago, Morton Scheinberg, Antonio Scotton, Ricardo Xavier, Cristiano Zerbini, Vladimir Kadinov, Nikolay Nikolov, Yuliy Spasov, Rumen Stoilov, Nadezhda Yordanova, Milton Baker, Isabelle Fortin, Algis Jovaisas, Clode Lessard, Jude Rodrigues, Alexander Yan, Irmgadt Goecke Sariego, Mirentxu Ines Iruretagoyena Bruce, Maria Martinez Ruiz-Esquide, Lucia Ponce Lerou, Xiao Zhang, Carlos Arteaga Unigarro, John Londono Patino, Jose Molina Restrepo, William Otero Escalante, Federico Rondon Herrera, Patricia Velez-Sanchez, Ladislav Bortlik, Šárka Forejtová, Zdenka Mosterova, Petr Nemec, Libor Novosad, Vlastimil Racek, Jan Rosa, Zuzana Stejfova, Petr Vitek, Pentti Jarvinen, Heikki Valleala, Tsang Tommy Cheung, Chak Sing Lau, Ka Lai Lee, Chi-Chiu Mok, Lai Shan Tam, Howard Amital, Alexandra Balbir-Gurman, Ori Elkayam, Yair Levy, Merav Lidar, Andrey Markov, Dror Mevorach, Yair Molad, Tatiana Reitblat, Itzhak Rosner, Moshe Tishler, Devy Zisman, Khaldoon Alawneh, Jeries Daoud, Nadeen Hilal, Jeanine Menassa, Nelly Ziade, Ping Seung Ong, Azmillah Rosman, Wahinuddin Sulaiman, Cheng Lay The, Carlos Abud-Mendoza, Hilario Avila Armengol, Mario Cardiel Rios, Sandra Carillo Vazquez, Rafael Cornejo-Ballesteros, Jose Covarrubias Cobos, Sergio Gutierrez-Urena, Fedra Irazoque-Palazuelos, Marco Maradiaga Cecena, Cesar Pacheco-Tena, Virginia Pascual-Ramos, Juan Rizo Rodriguez, Isaura Rodriguez Torres, Reinhard Bos, Jacob Van Laar, Daniel Ching, Alan Doube, Sunil Kumar, Ketna Parekh, Ana Marisela Asmat Anhuaman, Alfredo Berrocal Kasay, Armando Calvo Quiroz, Jose Chavez Corrales, Elias Chalouhi El Khouri, Boris Garro Barrera, Manuel Leon-Portocarrero, Alejandro Miranda Pinto, Risto Perich Campos, Félix Romero Peña, Jan Brzezicki, Dariusz Chudzik, Magdalena Dmoszynska-Graniczka, Krystyna Dworak, Barbara Grabowicz-Wasko, Pawel Hrycaj, Slawomir Jeka, Marek Konieczny, Marek Krogulec, Jaroslaw Marcinkiewicz, Agnieszka Ewa Pawtel, Artur Racewicz, Maria Rell-Bakalarska, Zofia Ruzga, Karina Sitek-Ziolkowska, Maria Stopinska-Polaszewska, Anna Sylwestrzak, Leszek Szczepanski, Piotr Wiland, Agnieszka Zielinska, Grisell Ortiz-Lasanta, Jose Ramirez-Vazquez, Ramon Toro Torres, Alina Agafina, Grigory Arutyunov, Valeria Esip, Elena Grunina, Nadezhda Izmozherova, Natalya Khalaydzhi, Irina Marusenko, Tatyana Mikhaylova, Andrey Sarana, Ivan Shirinsky, Evgeniya Shmidt, Olga Stetsiouk, Peter Belica, Livia Bruskova, Pavol Dobrovodsky, Viola Husarova, Roman Jancovic, Andrea Skublova, Agnesa Szolnokiova, Johannes Breedt, Maria Du Plooy, Dina Janse Van Rensburg, Asgar Kalla, Faruq Khatib, Ingrid Louw, Savithree Nayiager, Jeanne Nel, Jennifer Potts, Helmuth Reuter, Catherine Spargo, Gareth Tarr, Elsa Van Duuren, Ricardo Blanco Alonso, Ivan Castellvi Barranco, Eugenio Chamizo Carmona, Antonio Fernandez Nebro, Maria Luz Garcia Vivar, Beatriz Joven Ibanez, Isabel Mateo Bernardo, Elisabet Montori Palacin, Carmen Moragues Pastor, Alberto Alonso Ruiz, Federico Navarro Sarabia, Jose Javier Perez Venegas, Manuel Enrique Pombo Suarez, Eduardo Ucar Angulo, Carmen Vargas Lebron, Ying-Ming Chiu, Chien-Chih Lai, Ning-Sheng Lai, Joung-Liang Lan, Hsiao-Yi Lin, Ming-Fei Liu, Mei-Ping Liu, Shue-Fen Luo, Ya-Chih Tien, Cheng-Chung Wei, Chia-Tse Weng, Paijit Asavatanabodee, Wanruchada Katchamart, Worawit Louthrenoo, Kanokrat Nantiruj, Boonjing Siripaitoon, Sebnem Ataman, Ayse Erguney Cefle, Savas Gursoy, Gulen Hatemi, Sami Hizmetli, Umut Kalyoncu, Omer Karadag, Senol Kobak, Omer Kuru, Ahmet Onat, Ali Taylan, Yasemin Turan, Hasan Ulusoy, Orhan Zengin, Teresa Doherty, Robert Moots, Wan Fai Ng, Selwyn Richards, Euthalia Roussou, Thomas Sheeran, David Walker, Jacob Aelion, Jeffrey Alloway, Cristina Arriens, Kwabena Ayesu, Herbert Baraf, Linda Belhorn, Anupama Bhat, Barbara Bode, Stephen Bookbinder, Mark Box, Timothy Brennan, James Calmes, Robert Capps, John Carter, Anurekha Chadha, Victor Chen, Melvin Churchill, Andreea Coca, Asif Cochinwala, Christine Codding, Jeffrey Curtis, Kathryn Dao, Craig Davis, John Davis, Nimesh Dayal, Belkis Delgado, Roger Diegel, Ara Dikranian, Erdal Diri, Geoffrey Dolan, Robin Dore, Sharon Dowell, Michelle Eisenberg, Mitchell Feinman, Justus Fiechtner, Beata Filip-Majewski, Joseph Forstot, Pamela Freeman, David Goddard, Marc Goldberg, Misael Gonzalez, John Gorman, Maria Greenwald, Robert Griffin, Ramesh Gupta, Dale Halter, Robert Harrell, Mark Harris, John Harshbarger, Douglas Haselwood, Sabine Hazan-Steinberg, Ammar Hemaidan, Geneva Hill, Diane Horowitz, Mary Howell, John Hull, Richard Jones, John Joseph, Vipul Joshi, Joshua June, Gurjit Kaeley, Kenneth Kalunian, George Karpouzas, Paul Katzenstein, Ratinder Kaur, Jonathan Kay, Kimberly Kendall, William Kim, Alan Kivitz, Steven Klein, Michael Kohen, Chian Kwoh, Robert LaGrone, Jeffrey Lawson, Clarence Legerton, Robert Levin, Roger Lidman, Jefrey Lieberman, Jeffrey Lisse, Mitchell Lowenstein, Michael Luggen, Basit Malik, Jyothi Mallepalli, Joan Merrill, Samy Metyas, Wesley Mizutani, Joseph Moran, Sabeen Najam, Nathaniel Neal, Tony Ning, Ghaith Noaiseh, Kurt Oelke, Ewa Olech, Meera Oza, Dennis Ozment, William Palmer, Dayton Payne, Samuel Pegram, Dianne Petrone, Jeffrey Poiley, Andrew Porges, Henry Prupas, Madura Rangaraj, Ronald Rapoport, Andreas Reimold, David Ridley, Jeffrey Ritter, Georgia Roane, Michael Robinson, Adam Rosen, Constantine Saadeh, Michael Sayers, William Schnitz, Anthony Sebba, William Shergy, Robert Shurmur, David Sikes, Atul Singhal, Yvonne Smallwood-Sherrer, Nowarat Songsiridej, Michael Stack, Melody St John, William Stohl, Tien-I Su, Dominick Sudano, Andrew Sulich, Prashanth Sunkureddi, Paul Sutej, Timothy Swartz, Suman Thakker, Aikaterini Thanou, Robert Trapp, Orrin Troum, David True, Yong-Hsiung Tsai, James Udell, Fehmida Zahabi Unwala, Jacqueline Vo, Philip Waller, Saleem Waraich, Nathan Wei, Charles Weidmann, Craig Wiesenhutter, Anne Winkler, Sanford Wolfe, Darice Yang, Karen Zagar |
| 3 | |
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis |
Front Immunol. 2021 Nov 18;12:729681.doi: 10.3389/fimmu.2021.729681. eCollection 2021. Liam J O'Neil 1 2, Pingzhao Hu 3 4, Qian Liu 3 4, Md Mohaiminul Islam 3 4, Victor Spicer 2, Juergen Rech 5, Axel Hueber 5, Vidyanand Anaparti 2, Irene Smolik 1, Hani S El-Gabalawy 1 2, Georg Schett 5, John A Wilkins 1 2 |
| 4 | |
Effects of a Weight and Pain Management Program in Patients With Rheumatoid Arthritis With Obesity: A Randomized Controlled Pilot Investigation |
J Clin Rheumatol. 2022 Jan 1;28(1):7-13.doi: 10.1097/RHU.0000000000001793. Tamara J Somers 1, James A Blumenthal 1, Caroline S Dorfman 1, Kim M Huffman 2, Sara N Edmond, Shannon N Miller 1, Anava A Wren 3, David Caldwell 4, Francis J Keefe 1 |
| 5 | |
Evaluating filgotinib for the treatment of rheumatoid arthritis |
Expert Opin Pharmacother. 2021 Dec;22(18):2435-2444.doi: 10.1080/14656566.2021.1967929. Epub 2021 Aug 26. |
| 6 | |
Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits |
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1809-1814. doi: 10.1002/acr.24429. Bryant R England 1, Claire E H Barber 2, Martin Bergman 3, Veena K Ranganath 4, Lisa G Suter 5, Kaleb Michaud 6 |
| 7 | |
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial |
Arthritis Rheumatol. 2021 Dec;73(12):2206-2218.doi: 10.1002/art.41953. Epub 2021 Nov 1. Aaron Winkler 1, Weiyong Sun 1, Saurav De 2, Aiping Jiao 1, M Nusrat Sharif 1, Peter T Symanowicz 1, Shruti Athale 3, Julia H Shin 1, Ju Wang 1, Bruce A Jacobson 1, Simeon J Ramsey 1, Ken Dower 1, Tatyana Andreyeva 1, Heng Liu 1, Martin Hegen 1, Bruce L Homer 1, Joanne Brodfuehrer 1, Mera Tilley 1, Steven A Gilbert 1, Spencer I Danto 1, Jean J Beebe 1, Betsy J Barnes 2, Virginia Pascual 3, Lih-Ling Lin 1, Iain Kilty 1, Margaret Fleming 1, Vikram R Rao 1 |
| 8 | |
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies |
Arthritis Res Ther. 2022 Jan 3;24(1):11. doi: 10.1186/s13075-021-02677-7. Clifton O Bingham 3rd 1, David Walker 2, Peter Nash 3, Susan J Lee 4, Lei Ye 4, Hao Hu 4, Javaria Mona Khalid 5, Bernard Combe 6 |
| 9 | |
Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants |
Clin Pharmacol Drug Dev. 2022 Feb;11(2):235-245.doi: 10.1002/cpdd.1015. Epub 2021 Sep 1. Kacey Anderson 1, Cara H Nelson 1, Qi Gong 1, Muhsen Alani 1 2, Thomas Tarnowski 1, Ahmed A Othman 1 |
| 10 | |
Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Feb;74(2):229-235. doi: 10.1002/acr.24469.Epub 2022 Jan 5. |
| 11 | |
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis |
Rheumatol Ther. 2022 Apr;9(2):649-661. doi: 10.1007/s40744-022-00429-w.Epub 2022 Feb 20. Roy Fleischmann 1, Kyle Hayes 2, Sung-Woo Ahn 3, George J Wan 2, Mary Panaccio 2, Daniel Karlsson 2, Daniel E Furst 4 |
| 12 | |
Circulating Adipokines and Associations with Incident Cardiovascular Disease in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Mar 21. doi: 10.1002/acr.24885. Online ahead of print. Lydia E Federico 1, Tate M Johnson 2 3, Bryant R England 2 3, Katherine D Wysham 4 5, Michael D George 1 6, Brian Sauer 7 8, Bartlett C Hamilton 3, Carlos D Hunter 3, Michael J Duryee 3, Geoffrey M Thiele 2 3, Ted R Mikuls 2 3, Joshua F Baker 1 6 9 |
| 13 | |
Investigation Into the Effect of COVID-19 Infection on Length of Hospital Stay and Mortality in Patients With Rheumatoid Arthritis |
Cureus. 2022 Feb 28;14(2):e22685. doi: 10.7759/cureus.22685. eCollection 2022 Feb. Kevin Thompson 1, Ami Shah 2, Adam Grunbaum 3, Olu Oyesanmi 4 |
| 14 | |
Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis |
Clin Exp Rheumatol. 2022 Jan 25. doi: 10.55563/clinexprheumatol/8snr4x. Online ahead of print. Isaac D Smith 1, Na Lu 2, Jie Wei 2, Yuqing Zhang 2, Hyon K Choi 2, Marcy B Bolster 2 |
| 15 | |
Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey |
J Rheumatol. 2022 Mar 1;jrheum.210688. doi: 10.3899/jrheum.210688. Online ahead of print. Glen S Hazlewood 1, Orit Schieir 1, Vivian Bykerk 1, Kamso Mujaab 1, Peter Tugwell 1, George Wells 1, Dawn Richards 1, Laurie Proulx 1, Pauline M Hull 1, Susan J Bartlett 1 |
| 16 | |
The Use of Telehealth for Psychological Counselling of Vulnerable Adult Patients With Rheumatic Diseases or Diabetes: Explorative Study Inspired by Participatory Design |
JMIR Hum Factors. 2022 Mar 21;9(1):e30829. doi: 10.2196/30829. Mette Juel Rothmann 1 2 3 4, Julie Drotner Mouritsen 1 2, Nanna Skov Ladefoged 1 2, Marie Nedergaard Jeppesen 2, Anna Sofie Lillevang 1 2, Helle Laustrup 1 4, Torkell Ellingsen 1 4 |
| 17 | |
Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework |
MIR Res Protoc. 2022 Mar 22;11(3):e16430. doi: 10.2196/16430. Lisa Nugent # 1, Robin Anthony Kouyate # 1, Shawna Jackson # 1, Meredith Y Smith # 1 |
| 18 | |
Oral surveillance and JAK inhibitor safety: the theory of relativity |
Nat Rev Rheumatol. 2022 Mar 22;1-4. doi: 10.1038/s41584-022-00767-7.Online ahead of print. Kevin L Winthrop 1, Stanley B Cohen 2 |
| 19 | |
Elevations in Adipocytokines and Mortality in Rheumatoid Arthritis |
Rheumatology (Oxford). 2022 Mar 23;keac191. doi: 10.1093/rheumatology/keac191.Online ahead of print. Joshua F Baker 1 2 3, Bryant R England 4, Michael D George 2 3, Katherine Wysham 5 6, Tate Johnson 4, Gary Kunkel 7, Brian Sauer 7, Bartlett C Hamilton 4, Carlos D Hunter 4, Michael J Duryee 4, Paul Monach 8, Gail Kerr 9, Andreas Reimold 10, Rui Xiao 3, Geoff M Thiele 4, Ted R MIkuls 4 |
| 20 | |
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis |
Rheumatol Ther. 2022 Mar 18. doi: 10.1007/s40744-022-00439-8. Online ahead of print. Roy M Fleischmann 1, Amy E Bock 2, Wuyan Zhang 3, Charles M Godfrey 4, Ivana Vranic 5, Carol Cronenberger 6, Eva Dokoupilová 7 8 |
| 21 | |
Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies |
J Rheumatol. 2022 Mar 15;jrheum.211242. doi: 10.3899/jrheum.211242. Online ahead of print. Gregory McDermott 1, Ritu Gill 1, Staci Gagne 1, Suzanne Byrne 1, Weixing Huang 1, Xiaosong Wang 1, Lauren C Prisco 1, Alessandra Zaccardelli 1, Lily W Martin 1, Lucy Masto 1, Vanessa L Kronzer 1, Nancy Shadick 1, Paul F Dellaripa 1, Tracy J Doyle 1, Jeffrey A Sparks 1 |
| 22 | |
Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
J Rheumatol. 2022 Mar 15;jrheum.211020. doi: 10.3899/jrheum.211020. Online ahead of print. Brook Hadwen 1, Richard Yu 1, Ewa Cairns 1, Lillian Barra 1 |
| 23 | |
Associations of the MUC5B Promoter Variant with Timing of Interstitial Lung Disease and Rheumatoid Arthritis Onset |
Rheumatology (Oxford). 2022 Mar 15;keac152. doi: 10.1093/rheumatology/keac152.Online ahead of print. Gregory McDermott 1 2, Ritu Gill 3 2, Staci Gagne 4 2, Suzanne Byrne 4 2, Weixing Huang 1, Jing Cui 1 2, Lauren Prisco 1, Alessandra Zaccardelli 1, Lily Martin 1, Vanessa L Kronzer 5, Matthew Moll 6 7 2, Michael H Cho 6 7 2, Nancy Shadick 1 2, Paul F Dellaripa 1 2, Tracy Doyle 6 2, Jeffrey A Sparks 1 2 |
| 24 | |
Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy |
RMD Open. 2022 Mar;8(1):e001994. doi: 10.1136/rmdopen-2021-001994. Peter C Taylor 1, Rieke Alten 2, Jose María Álvaro Gracia 3, Yuko Kaneko 4, Chad Walls 5, Amanda Quebe 5, Bochao Jia 5, Natalia Bello 5, Jorge Ross Terres 5, Roy Fleischmann 6 |
| 25 | |
Microstructural Bone Changes Are Associated With Broad-Spectrum Autoimmunity and Predict the Onset of Rheumatoid Arthritis |
Arthritis Rheumatol. 2022 Mar;74(3):418-426. doi: 10.1002/art.41229. Epub 2022 Jan 27. David Simon 1, Arnd Kleyer 1, Duy Bui Cong 1, Axel Hueber 1, Holger Bang 2, Andreas Ramming 1, Juergen Rech 1, Georg Schett 1 |
| 26 | |
Defining Minimum Clinically Important Changes for the Patient Activity Scale II |
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1456-1460.doi: 10.1002/acr.24335. Epub 2021 Aug 20. Joshua F Baker 1, Patti Katz 2, Kaleb Michaud 3 |
| 27 | |
Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis |
Hand (N Y). 2022 Mar;17(2):271-277. doi: 10.1177/1558944720926631. Epub 2020 Jun 2. Matthew R Claxton 1, Eric R Wagner 2, Marco Rizzo 1 |
| 28 | |
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis |
Expert Rev Clin Immunol. 2022 Mar 2. doi: 10.1080/1744666X.2022.2049242.Online ahead of print. Vibeke Strand 1 |
| 29 | |
Obesity and Response to Advanced Therapies in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Feb 10. doi: 10.1002/acr.24867. Online ahead of print. Joshua F Baker 1 2 3, George Reed 4, Dilli Ram Poudel 5, Leslie R Harrold 4 6, Joel M Kremer 4 7 |
| 30 | |
Recent issues in JAK inhibitor safety: perspective for the clinician |
Expert Rev Clin Immunol. 2022 Feb 10;1-13. doi: 10.1080/1744666X.2022.2039122.Online ahead of print. Roy Fleischmann 1 2 |
| 31 | |
Patient Goals for Living with Rheumatoid Arthritis: A Qualitative Study |
Clin Nurs Res. 2022 Feb 7;10547738221075784. doi: 10.1177/10547738221075784.Online ahead of print. Melanie J Cozad 1, Lisa C Lindley 2, Kaitlyn Crosby 3, Noor Alshareef 4, Ann Blair Kennedy 5, Gulzar Merchant 6, Pam Evans 7, Ronnie D Horner 1 |
| 32 | |
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study |
RMD Open. 2022 Feb;8(1):e002012. doi: 10.1136/rmdopen-2021-002012. Roy Fleischmann 1, Eduardo Mysler 2, Louis Bessette 3, Charles G Peterfy 4, Patrick Durez 5, Yoshiya Tanaka 6, Jerzy Swierkot 7, Nasser Khan 8, Xianwei Bu 8, Yihan Li 8, In-Ho Song 8 |
| 33 | |
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials |
Ann Rheum Dis. 2022 Feb;81(2):206-213. doi: 10.1136/annrheumdis-2021-220822.Epub 2021 Oct 6. Kevin L Winthrop 1, Peter Nash 2, Kunihiro Yamaoka 3, Eduardo Mysler 4, Nasser Khan 5, Heidi S Camp 5, Yanna Song 5, Jessica L Suboticki 5, Jeffrey R Curtis 6 |
| 34 | |
The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis |
Clin Exp Rheumatol. 2021 Sep 21. Online ahead of print. |
| 35 | |
Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis |
Front Immunol. 2021 Sep 14;12:715997. doi: 10.3389/fimmu.2021.715997. eCollection 2021. Liam J O'Neil 1, Christopher B Oliveira 1, Donavon Sandoval-Heglund 1, Ana Barrera-Vargas 2, Javier Merayo-Chalico 2, Eduardo Aguirre-Aguilar 2, Mariana J Kaplan 1, Carmelo Carmona-Rivera 1 |
| 36 | |
Filgotinib as rheumatoid arthritis therapy |
Drugs Today (Barc). 2021 Sep;57(9):543-550. doi: 10.1358/dot.2021.57.9.3317241. A Becciolini 1, E Di Donato 2, D Santilli 2, G Lucchini 2, F Mozzani 2, M Riva 2, A Ariani 2 |
| 37 | |
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis |
Adv Ther. 2021 Dec;38(12):5649-5661. doi: 10.1007/s12325-021-01930-4. Epub 2021 Oct 12. Martin Bergman 1, Namita Tundia 2, Min Yang 3, Eli Orvis 3, Jerry Clewell 2, Arielle Bensimon 4 |
| 38 | |
Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model |
Int J Mol Sci. 2021 Jul 5;22(13):7224. doi: 10.3390/ijms22137224. Alexander Otahal 1, Karina Kramer 1, Olga Kuten-Pella 2, Lukas B Moser 1, Markus Neubauer 1, Zsombor Lacza 2 3, Stefan Nehrer 1, Andrea De Luna 1 |
| 39 | |
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders |
Allergy. 2021 Sep;76(9):2673-2683. doi: 10.1111/all.14704. Epub 2020 Dec 26. Celine Kaegi 1, Urs C Steiner 1, Benjamin Wuest 1, Catherine Crowley 1, Onur Boyman 1 2 |
| 40 | |
Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists' beliefs |
Rheumatology (Oxford). 2021 Aug 2;60(8):3570-3578.doi: 10.1093/rheumatology/keaa803. Gyanendra Pokharel 1, Rob Deardon 2, Sindhu R Johnson 3 4, George Tomlinson 4, Pauline M Hull 5, Glen S Hazlewood 5 6 |
| 42 | |
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease |
Rheumatology (Oxford). 2021 Aug 2;60(8):3778-3788. doi: 10.1093/rheumatology/keaa860. Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 43 | |
Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study |
Rheumatology (Oxford). 2021 Jul 1;60(7):3334-3342. doi: 10.1093/rheumatology/keaa785. T Santiago 1 2, M Voshaar 3, M de Wit 4, P D Carvalho 5 6 7, F Buttgereit 8, M Cutolo 9, S Paolino 9, G R Castelar Pinheiro 10, M Boers 11, J A P Da Silva 1 2 |
| 44 | |
Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review |
Rheumatol Ther. 2021 Dec 28. doi: 10.1007/s40744-021-00407-8.Online ahead of print. Philip J Mease 1 2, Mohit Kumar Bhutani 3, Steven Hass 4, Esther Yi 5, Peter Hur 5, Nina Kim 6 7 |
| 47 | |
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study |
Clin Exp Rheumatol. Jul-Aug 2021;39(4):868-873. Epub 2020 Dec 18. Giacomo Maria Guidelli 1, Ombretta Viapiana 2, Nicoletta Luciano 1, Maria De Santis 1, Nicola Boffini 3, Luca Quartuccio 4, Domenico Birra 5, Edoardo Conticini 6, Maria Sole Chimenti 7, Chiara Bazzani 8, Eleonora Bruschi 9, Marta Riva 10, Lorenzo Maria Canziani 11, Gerolamo Bianchi 12, Maria Rosa Pozzi 10, Massimiliano Limonta 9, Roberto Gorla 8, Roberto Perricone 7, Bruno Frediani 6, Paolo Moscato 5, Salvatore De Vita 4, Lorenzo Dagna 3, Maurizio Rossini 2, Carlo Selmi 13 |
| 49 | |
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis |
Ann Rheum Dis. 2021 Jul;80(7):884-890. doi: 10.1136/annrheumdis-2020-218744.Epub 2021 Jan 12. Irina Gessl 1, Mihaela Popescu 2, Victoria Schimpl 3, Gabriela Supp 1, Thomas Deimel 1, Martina Durechova 1, Miriam Hucke 4, Michaela Loiskandl 1, Paul Studenic 1, Michael Zauner 1, Josef S Smolen 1, Daniel Aletaha 1, Peter Mandl 5 |
| 50 | |
Widespread non-joint pain in early rheumatoid arthritis |
Scand J Rheumatol. 2021 Jul;50(4):271-279. doi: 10.1080/03009742.2020.1846778.Epub 2021 Feb 25. Mec Schelin 1 2, H Westerlind 3 4, J Lindqvist 5 6, E Englid 5, L Israelsson 5, E Skillgate 3, L Klareskog 5 6, L Alfredsson 3, J Lampa 5 6 |
| 51 | |
Higher mortality rates associated with rheumatoid arthritis in Saskatchewan, Canada, 2001-2019 |
Can J Public Health. 2021 Aug;112(4):722-732. doi: 10.17269/s41997-021-00476-w.Epub 2021 Feb 17. Regina M Taylor-Gjevre 1, Bindu V Nair 2, Shan Jin 3, Jacqueline Quail 3 4 |
| 52 | |
Outcomes of a Mobile App to Monitor Patient-Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial |
Arthritis Rheumatol. 2021 Aug;73(8):1421-1429.doi: 10.1002/art.41686. Epub 2021 Jun 18. Yvonne C Lee 1, Fengxin Lu 2, Joshua Colls 2, Dee Luo 2, Penny Wang 2, Dorothy D Dunlop 1, Lutfiyya N Muhammad 1, Jing Song 1, Kaleb Michaud 3, Daniel H Solomon 2 |
| 53 | |
Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study |
Rheumatology (Oxford). 2021 Oct 2;60(10):4681-4690. doi: 10.1093/rheumatology/keab078. Nadia M T Roodenrijs 1, Paco M J Welsing 1, Marlies C van der Goes 1 2, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 54 | |
Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Oct;73(10):1820-1830. doi: 10.1002/art.41744. Epub 2021 Aug 24. Nicola J Maney 1, Henrique Lemos 1, Ben Barron-Millar 1, Christopher Carey 1, Ian Herron 1, Amy E Anderson 1, Andrew L Mellor 1, John D Isaacs 2, Arthur G Pratt 2 |
| 55 | |
Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation |
Arthritis Rheumatol. 2021 Jun;73(6):970-979. doi: 10.1002/art.41613. Epub 2021 May 9. Brittany Weber 1, Zeling He 1, Nicole Yang 1, Martin P Playford 2, Dana Weisenfeld 1, Christine Iannaccone 1, Jonathan Coblyn 1, Michael Weinblatt 1, Nancy Shadick 1, Marcelo Di Carli 1, Nehal N Mehta 2, Jorge Plutzky 1, Katherine P Liao 3 |
| 56 | |
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939. doi: 10.1002/acr.24596. Epub 2021 Jun 8. Liana Fraenkel 1, Joan M Bathon 2, Bryant R England 3, E William St Clair 4, Thurayya Arayssi 5, Kristine Carandang 6, Kevin D Deane 7, Mark Genovese 8, Kent Kwas Huston 9, Gail Kerr 10, Joel Kremer 11, Mary C Nakamura 12, Linda A Russell 13, Jasvinder A Singh 14, Benjamin J Smith 15, Jeffrey A Sparks 16, Shilpa Venkatachalam 17, Michael E Weinblatt 16, Mounir Al-Gibbawi 18, Joshua F Baker 19, Kamil E Barbour 20, Jennifer L Barton 21, Laura Cappelli 22, Fatimah Chamseddine 18, Michael George 23, Sindhu R Johnson 24, Lara Kahale 18, Basil S Karam 18, Assem M Khamis 18, Iris Navarro-Millán 25, Reza Mirza 26, Pascale Schwab 21, Namrata Singh 27, Marat Turgunbaev 28, Amy S Turner 28, Sally Yaacoub 18, Elie A Akl 18 |
| 57 | |
"Associations of Rheumatoid Arthritis and Depressive Symptoms over Time: Are there Differences by Education, Race/Ethnicity, and Gender?" |
Arthritis Care Res (Hoboken). 2021 Jun 13. doi: 10.1002/acr.24730. Online ahead of print. Julia T McQuillan 1, Jennifer A Andersen 2, Terceira A Berdahl 3, Jeff Willett 4 |
| 58 | |
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions |
Front Pharmacol. 2021 May 28;12:680043. doi: 10.3389/fphar.2021.680043.eCollection 2021. Shahin Shams 1, Joseph M Martinez 2, John R D Dawson 3, Juan Flores 4, Marina Gabriel 1, Gustavo Garcia 1, Amanda Guevara 2, Kaitlin Murray 5, Noah Pacifici 1, Maxemiliano V Vargas 6, Taylor Voelker 3, Johannes W Hell 2, Judith F Ashouri 7 |
| 59 | |
The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis |
Cardiovasc Endocrinol Metab. 2021 Feb 19;10(2):125-131.doi: 10.1097/XCE.0000000000000244. eCollection 2021 Jun. Zixing Tian 1, John Mclaughlin 1, Arpana Verma 2, Hector Chinoy 3 4 5, Adrian H Heald 1 1 |
| 60 | |
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8 Liana Fraenkel 1, Joan M Bathon 2, Bryant R England 3, E William St Clair 4, Thurayya Arayssi 5, Kristine Carandang 6, Kevin D Deane 7, Mark Genovese 8, Kent Kwas Huston 9, Gail Kerr 10, Joel Kremer 11, Mary C Nakamura 12, Linda A Russell 13, Jasvinder A Singh 14, Benjamin J Smith 15, Jeffrey A Sparks 16, Shilpa Venkatachalam 17, Michael E Weinblatt 16, Mounir Al-Gibbawi 18, Joshua F Baker 19, Kamil E Barbour 20, Jennifer L Barton 21, Laura Cappelli 22, Fatimah Chamseddine 18, Michael George 23, Sindhu R Johnson 24, Lara Kahale 18, Basil S Karam 18, Assem M Khamis 18, Iris Navarro-Millán 25, Reza Mirza 26, Pascale Schwab 21, Namrata Singh 27, Marat Turgunbaev 28, Amy S Turner 28, Sally Yaacoub 18, Elie A Akl 18 |
| 61 | |
Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door |
J Rheumatol. 2021 Jun 1;jrheum.210224. doi: 10.3899/jrheum.210224.Online ahead of print. |
| 62 | |
Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom |
Rheumatology (Oxford). 2021 Jun 3;keab464. doi: 10.1093/rheumatology/keab464.Online ahead of print. Peter C Taylor 1, Matthew Woods 2, Catherine Rycroft 2, Priya Patel 3, Sophee Blanthorn-Hazell 3, Toby Kent 3, Marwan Bukhari 4 |
| 63 | |
What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction? |
ACR Open Rheumatol. 2021 Jul;3(7):457-463. doi: 10.1002/acr2.11266. Epub 2021 Jun 4. Helga Westerlind 1, Mateusz Maciejewski 2, Thomas Frisell 1, Scott A Jelinsky 2, Daniel Ziemek 2, Johan Askling 1 |
| 66 | |
Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests |
J Rheumatol. 2021 May 15;jrheum.201510. doi: 10.3899/jrheum.201510.Online ahead of print. Johannes W G Jacobs 1, Maxime M A Verhoeven 1, Paco M J Welsing 1 |
| 67 | |
Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis |
J Rheumatol. 2021 May 15;jrheum.201439. doi: 10.3899/jrheum.201439. Online ahead of print. Sanketh Rampes 1, Vishit Patel 1, Ailsa Bosworth 1, Clare Jacklin 1, Deepak Nagra 1, Mark Yates 1, Sam Norton 1, James Galloway 1 |
| 68 | |
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis |
Front Immunol. 2021 Apr 29;12:673916. doi: 10.3389/fimmu.2021.673916.eCollection 2021. Sally A Clayton 1 2, Lucy MacDonald 3 4, Mariola Kurowska-Stolarska 3 4, Andrew R Clark 1 2 |
| 69 | |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis |
Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220125.doi: 10.1136/annrheumdis-2021-220125. Online ahead of print. Tate M Johnson 1 2, Harlan R Sayles 1 3, Joshua F Baker 4 5, Michael D George 4 5, Punyasha Roul 1, Cheng Zheng 3, Brian Sauer 6 7, Katherine P Liao 8, Daniel R Anderson 9, Ted R Mikuls 1 2, Bryant R England 10 2 |
| 70 | |
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning |
J Rheumatol. 2021 May 1;jrheum.201626. doi: 10.3899/jrheum.201626. Online ahead of print. Fredrik D Johansson 1, Jamie E Collins 1, Vincent Yau 1, Hongshu Guan 1, Seoyoung C Kim 1, Elena Losina 1, David Sontag 1, Jacklyn Stratton 1, Huong Trinh 1, Jeffrey Greenberg 1, Daniel H Solomon 1 |
| 71 | |
The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report |
J Clin Apher. 2021 May 4. doi: 10.1002/jca.21903. Online ahead of print. Allen P Green 1, Adam C Gonzalez 2, Jack B Alperin 3, James D Burner 1, Sean G Yates 1 |
| 72 | |
Clinical use of Jak 1 inhibitors for rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii31-ii38.doi: 10.1093/rheumatology/keab265. |
| 73 | |
Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii17-ii23.doi: 10.1093/rheumatology/keaa823. |
| 74 | |
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort |
Int Immunopharmacol. 2021 Apr 29;97:107719. doi: 10.1016/j.intimp.2021.107719.Online ahead of print. Bryant R England 1, Megan Campany 2, Harlan Sayles 2, Punyasha Roul 2, Yangyuna Yang 2, Apar Kishor Ganti 3, Jeremy Sokolove 4, William H Robinson 5, Andreas M Reimold 6, Gail S Kerr 7, Grant W Cannon 8, Brian C Sauer 8, Joshua F Baker 9, Geoffrey M Thiele 10, Ted R Mikuls 10 |
| 75 | |
Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Jun 11. doi: 10.1002/art.41899. Online ahead of print. Angela Mc Ardle 1, Anna Kwasnik 1, Agnes Szenpetery 1, Belinda Hernandez 2 3, Andrew Parnell 3, Wilco de Jager 4 5, Sytze de Roock 5, Oliver FitzGerald 1, Stephen R Pennington 1 |
| 76 | |
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study |
Medicine (Baltimore). 2021 Apr 30;100(17):e25481. doi: 10.1097/MD.0000000000025481. Alberto Floris 1, Daniela Perra 1, Ignazio Cangemi 1, Mattia Congia 1, Elisabetta Chessa 1, Maria Maddalena Angioni 1, Arduino Aleksander Mangoni 2, Gian Luca Erre 3, Alessandro Mathieu 1, Matteo Piga 1, Alberto Cauli 3 |
| 77 | |
Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study |
Rheumatology (Oxford). 2021 Apr 26;keab388. doi: 10.1093/rheumatology/keab388.Online ahead of print. Toby O Smith 1 2, Celia Clarke 1, Jack R Dainty 1, Laura Watts 1, Max Yates 1 3, Valerie M Pomeroy 1 4, Emma Stanmore 5, Terence W O'Neill Tw 6, Alexander J Macgregor 1 3 |
| 78 | |
Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review |
JBJS Rev. 2021 Jun 8;9(6). doi: 10.2106/JBJS.RVW.20.00201. Noah E Saunders 1, James R Holmes 2, David M Walton 2, Paul G Talusan 3 |
| 79 | |
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift) |
RMD Open. 2021 Jun;7(2):e001673. doi: 10.1136/rmdopen-2021-001673. Stanley B Cohen 1, Janet Pope 2, Boulos Haraoui 3, Eduardo Mysler 4, Annette Diehl 5, Tatjana Lukic 6, Shixue Liu 7, Lori Stockert 5, Rebecca Germino 6, Sujatha Menon 8, Harry Shi 6, Edward C Keystone 9 |
| 80 | |
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors |
Rheumatology (Oxford). 2021 Apr 19;keab355. doi: 10.1093/rheumatology/keab355.Online ahead of print. Roy Fleischmann 1, Mark C Genovese 2, Karina Maslova 3, Henry Leher 4, Amy Praestgaard 5, Gerd R Burmester 6 |
| 81 | |
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial |
RMD Open. 2021 Apr;7(1):e001627. doi: 10.1136/rmdopen-2021-001627. Juliana Rachel Hoeper 1 2, Jan Zeidler 1, Sara Eileen Meyer 2, Georg Gauler 3, Patricia Steffens-Korbanka 3, Martin Welcker 4, Jörg Wendler 5, Florian Schuch 5, Ulrich von Hinüber 6, Andreas Schwarting 7 8, Torsten Witte 2, Dirk Meyer-Olson 2 9, Kirsten Hoeper 10 |
| 82 | |
Demyelinating Events Following Initiation of Anti-TNFa Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis |
Neurol Neuroimmunol Neuroinflamm. 2021 Apr 16;8(3):e992.doi: 10.1212/NXI.0000000000000992. Print 2021 May. Thomas R P Taylor 1, James Galloway 1, Rebecca Davies 1, Kimme Hyrich 1, Ruth Dobson 2 |
| 83 | |
Epstein-Barr virus -related lymphoma in rheumatoid arthritis: Implications for long-term usage of immunosuppressive drugs and review of the literature |
Intern Med J. 2021 May 24. doi: 10.1111/imj.15390. Online ahead of print. Jianna He 1, Luke Williamson 1, Ken Cai 1, Peter Wong 1 2, Allan Sturgess 3, John Taper 4, Nicholas Manolios 1 5 |
| 84 | |
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study |
Rheumatol Ther. 2021 May 24. doi: 10.1007/s40744-021-00317-9. Online ahead of print. Alvin F Wells 1, Bochao Jia 2, Li Xie 2, Guillermo J Valenzuela 3, Edward C Keystone 4, Zhanguo Li 5, Amanda K Quebe 6, Kirstin Griffing 2, Susan Otawa 2, Boulos Haraoui 7 |
| 85 | |
Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured? |
Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41801. Online ahead of print. |
| 86 | |
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-Based Network |
Arthritis Care Res (Hoboken). 2021 May 10. doi: 10.1002/acr.24626. Online ahead of print. Michael George 1, Maria I Danila 2, Daniel Watrous 3, Shanmugapriya Reddy 4, Jeffrey Alper 5, Fenglong Xie 2, W Benjamin Nowell 6, Joel Kallich 7, Cassie Clinton 2, Kenneth G Saag 2, Jeffrey R Curtis 2 |
| 87 | |
Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis |
J Rheumatol. 2021 Mar 15;jrheum.200990. doi: 10.3899/jrheum.200990. Online ahead of print. Jennifer L Beaumont 1, Elizabeth S Davis 1, James F Fries 1, Jeffrey R Curtis 1, David Cella 1, Huifeng Yun 1 |
| 88 | |
Role of Janus Kinase inhibitors in rheumatoid arthritis treatment |
Curr Opin Rheumatol. 2021 May 1;33(3):300-306. doi: 10.1097/BOR.0000000000000792. |
| 89 | |
Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials |
Rheumatol Ther. 2021 Apr 2. doi: 10.1007/s40744-021-00302-2. Online ahead of print. Catherine B McGuiness 1, Natalie N Boytsov 2, Xiang Zhang 2, Xin Wang 3, Carol L Kannowski 2, Rolin L Wade 3 |
| 90 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 91 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 92 | |
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups |
J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403. |
| 93 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 94 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 95 | |
Discrepancy Between Multi-Biomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print. Roy Fleischmann 1, Jingyu Liu 2, Julie Zhu 2, Oscar G Segurado 3, Daniel E Furst 4 |
| 96 | |
The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database |
Rheumatology (Oxford). 2021 Apr 30;keab389. doi: 10.1093/rheumatology/keab389.Online ahead of print. Mrinalini Dey 1 2, Sizheng S Zhao 1 2, Robert J Moots 2 3, Sytske Anne Bergstra 4, Robert B Landewe 5 6, Nicola J Goodson 2 |
| 97 | |
Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial |
ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11256. Online ahead of print. Jon T Giles 1, Pamela M Rist 2, Katherine P Liao 2, Ahmed Tawakol 3, Zahi A Fayad 4, Venkatesh Mani 4, Nina P Paynter 2, Paul M Ridker 2, Robert J Glynn 2, Fengxin Lu 5, Rachel Broderick 1, Meredith Murray 5, Kathleen M M Vanni 5, Daniel H Solomon 2, Joan M Bathon 1 |
| 98 | |
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic |
Expert Rev Clin Immunol. 2021 Apr 14;1-11. doi: 10.1080/1744666X.2021.1908887.Online ahead of print. Ennio Giulio Favalli 1, Gabriella Maioli 1, Martina Biggioggero 1, Roberto Caporali 1 2 |
| 99 | |
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study |
Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021. Peter C Taylor 1, Codrina Ancuta 2, Orsolya Nagy 3, María C de la Vega 4, Andrey Gordeev 5, Radka Janková 6, Umut Kalyoncu 7, Ivan Lagunes-Galindo 3, Jadranka Morovic-Vergles 8, Mariana Peixoto G U E Silva de Souza 9, Bernadette Rojkovich 10, Prodromos Sidiropoulos 11, Atsushi Kawakami 12 |
| 100 | |
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof |
J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952.Epub 2021 Feb 11. Ryan R Davis 1, Baoli Li 1, Sang Y Yun 2, Alice Chan 1, Pradeep Nareddy 1, Steven Gunawan 1, Muhammad Ayaz 2, Harshani R Lawrence 2, Gary W Reuther 3, Nicholas J Lawrence 1, Ernst Schönbrunn 1 |
| 101 | |
Managing Cardiovascular Risk in Patients with Rheumatic Disease |
Med Clin North Am. 2021 Mar;105(2):247-262. doi: 10.1016/j.mcna.2020.09.010.Epub 2021 Jan 14. |
| 102 | |
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights |
Expert Rev Clin Pharmacol. 2021 Apr 13;1-10. doi: 10.1080/17512433.2021.1913050.Online ahead of print. Maria Gabriella Raimondo 1, Martina Biggioggero 2, Lavinia Agra Coletto 3, Andreas Ramming 1, Roberto Caporali 2 3, Ennio Giulio Favalli 2 |
| 103 | |
Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail! |
Arthritis Rheumatol. 2021 Mar 28. doi: 10.1002/art.41746. Online ahead of print. |
| 104 | |
Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study |
Osteoporos Int. 2021 Feb 11. doi: 10.1007/s00198-021-05862-1. Online ahead of print. |
| 105 | |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry |
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.Epub 2020 May 29. Milena Gianfrancesco # 1, Kimme L Hyrich # 2 3, Sarah Al-Adely 2 3, Loreto Carmona 4, Maria I Danila 5, Laure Gossec 6 7, Zara Izadi 1, Lindsay Jacobsohn 1, Patricia Katz 1, Saskia Lawson-Tovey 3 8, Elsa F Mateus 9, Stephanie Rush 1, Gabriela Schmajuk 1, Julia Simard 10, Anja Strangfeld 11, Laura Trupin 1, Katherine D Wysham 12, Suleman Bhana 13, Wendy Costello 14, Rebecca Grainger 15, Jonathan S Hausmann 16 17, Jean W Liew 12, Emily Sirotich 18 19, Paul Sufka 20, Zachary S Wallace 17 21, Jinoos Yazdany # 1, Pedro M Machado # 22 23 24, Philip C Robinson # 25 26, COVID-19 Global Rheumatology Alliance |
| 106 | |
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry |
ACR Open Rheumatol. 2021 Mar;3(3):173-184. doi: 10.1002/acr2.11232. Epub 2021 Feb 11. Joel M Kremer 1, Clifton O Bingham 3rd 2, Laura C Cappelli 2, Jeffrey D Greenberg 3, Ann M Madsen 4, Jamie Geier 4, Jose L Rivas 5, Alina M Onofrei 6, Christine J Barr 6, Dimitrios A Pappas 7, Heather J Litman 6, Kimberly J Dandreo 6, Andrea B Shapiro 8, Carol A Connell 9, Arthur Kavanaugh 10 |
| 107 | |
The Online Sharing of Instagram Images for Rheumatoid Arthritis |
Comput Inform Nurs. 2020 Jul 24;39(2):89-96. doi: 10.1097/CIN.0000000000000660. |
| 108 | |
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review |
J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509. Peter C Taylor 1, Fabiola Atzeni 2, Alejandro Balsa 3, Laure Gossec 4 5, Ulf Müller-Ladner 6, Janet Pope 7 |
| 109 | |
Peripheral Ulcerative Keratitis in Rheumatoid Arthritis Patients Taking Tocilizumab: Paradoxical Manifestation or Insufficient Efficacy? |
Rheumatology (Oxford). 2021 Feb 2;keab093. doi: 10.1093/rheumatology/keab093.Online ahead of print. Florian Cohen 1, Eric Ernest Gabison 2, Sophie Stéphan 2, Rakiba Belkhir 3, Gaetane Nocturne 3 4, Anne-Laurence Best 1, Oscar Haigh 4, Emmanuel Barreau 1, Marc Labetoulle 1 4, Raphaele Seror 3, Antoine Rousseau 1 4 |
| 110 | |
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program |
Drug Saf. 2021 Feb 2. doi: 10.1007/s40264-020-01036-w. Online ahead of print. Philip G Conaghan 1, Eduardo Mysler 2, Yoshiya Tanaka 3, Barbara Da Silva-Tillmann 4, Tim Shaw 5, John Liu 4, Ryan Ferguson 4, Jeffrey V Enejosa 4, Stanley Cohen 6, Peter Nash 7, William Rigby 8, Gerd Burmester 9 |
| 111 | |
Location, location, location: how the tissue microenvironment affects inflammation in RA |
Nat Rev Rheumatol. 2021 Feb 1. doi: 10.1038/s41584-020-00570-2.Online ahead of print. Christopher D Buckley 1 2, Caroline Ospelt 3, Steffen Gay 3, Kim S Midwood 4 |
| 112 | |
Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs |
J Rheumatol. 2021 Feb 1;jrheum.201183. doi: 10.3899/jrheum.201183. Online ahead of print. Arthur Kavanaugh 1, Rene R Westhovens 1, Kevin L Winthrop 1, Susan J Lee 1, YingMeei Tan 1, Di An 1, Lei Ye 1, John S Sundy 1, Robin Besuyen 1, Luc Meuleners 1, Mykola Stanislavchuk 1, Alberto J Spindler 1, Maria Greenwald 1, Rieke Alten 1, Mark C Genovese 1
|
| 113 | |
Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US |
Rheumatol Ther. 2021 Jan 23. doi: 10.1007/s40744-020-00275-8. Online ahead of print. Alison Walton 1, Jim Paik 2, Amanda Quebe 2, Carol L Kannowski 2, Casey Choong 2, Seth Anderson 2, Justin K Owensby 3 |
| 115 | |
Corticosteroids: Review of the History, the Effectiveness, and Adverse Effects in the Treatment of Joint Pain |
Pain Physician. 2021 Jan;24(S1):S233-S246. |
| 116 | |
Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis |
Rheumatology (Oxford). 2021 Jan 25;keab029. doi: 10.1093/rheumatology/keab029.Online ahead of print. Ciara M O'Brien 1 2, Nikos Ntoumanis 3, Joan L Duda 1, George D Kitas 2, Jet J C S Veldhuijzen van Zanten 1 2, George S Metsios 2 4, Sally A M Fenton 1 2 |
| 117 | |
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review |
Rheumatol Int. 2021 Jan 29. doi: 10.1007/s00296-020-04773-4. Online ahead of print. Julie K Dawson 1, Edmond Quah 2, Ben Earnshaw 2, Constanta Amoasii 2, Tareg Mudawi 2, Lisa G Spencer 3 |
| 118 | |
Erectile Dysfunction and Cardiovascular Risk in Men with Rheumatoid Arthritis: A Population- Based Cohort Study |
J Rheumatol. 2021 Jan 15;jrheum.201226. doi: 10.3899/jrheum.201226. Online ahead of print. Katelynn M Wilton 1, Sara J Achenbach 1, John M Davis 3rd 1, Elena Myasoedova 1, Eric L Matteson 1, Cynthia S Crowson 1 |
| 119 | |
Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada |
J Rheumatol. 2020 Sep 1;jrheum.200688. doi: 10.3899/jrheum.200688. Online ahead of print. Claire E H Barber 1, Karen L Then 1, Victoria Bohm 1, Marc Hall 1, Deborah A Marshall 1, James A Rankin 1, Cheryl Barnabe 1, Glen S Hazlewood 1, Linda C Li 1, Dianne Mosher 1, Joanne Homik 1, Paul MacMullan 1, Karen Tsui 1, Kelly English 1, Diane Lacaille, RA Quality Measurement Delphi Panel Group |
| 120 | |
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial |
Ann Rheum Dis. 2021 Jan 15;annrheumdis-2020-219213.doi: 10.1136/annrheumdis-2020-219213. Online ahead of print. René Westhovens 1 2, William F C Rigby 3, Désirée van der Heijde 4, Daniel W T Ching 5, William Stohl 6, Jonathan Kay 7 8, Arvind Chopra 9, Beatrix Bartok 10, Franziska Matzkies 10, Zhaoyu Yin 10, Ying Guo 10, Chantal Tasset 11, John S Sundy 10 12, Angelika Jahreis 10, Neelufar Mozaffarian 13, Osvaldo Daniel Messina 14 15, Robert Bm Landewé 16 17, Tatsuya Atsumi 18, Gerd R Burmester 19 20 |
| 121 | |
Is gene expression among women with rheumatoid arthritis dysregulated during a postpartum flare? |
Arthritis Res Ther. 2021 Jan 18;23(1):30. doi: 10.1186/s13075-021-02418-w. Matthew Wright 1, Mette K Smed 2, J Lee Nelson 3 4, Jørn Olsen 5 6, Merete L Hetland 7 8, Vibeke Zoffmann 2 9, Damini Jawaheer 10 11 |
| 122 | |
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients |
Rheumatology (Oxford). 2021 Jan 18;keaa836. doi: 10.1093/rheumatology/keaa836.Online ahead of print. Jeffrey A Sparks 1 2, Yinzhu Jin 3, Soo-Kyung Cho 4, Seanna Vine 3, Rishi Desai 2 3, Tracy J Doyle 2 5, Seoyoung C Kim 1 2 3 |
| 123 | |
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab |
Biologics. 2021 Jan 6;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021. Timothy Fitzgerald 1, Richard Melsheimer 2, Marie-Hélène Lafeuille 3, Patrick Lefebvre 3, Laura Morrison 3, Kimberly Woodruff 1, Iris Lin 1, Bruno Emond 3 |
| 124 | |
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis |
Rheumatology (Oxford). 2021 Jan 12;keaa834. doi: 10.1093/rheumatology/keaa834.Online ahead of print. Andrew R Melville 1 2, Md Yuzaiful Md Yusof 1 2, John Fitton 1 2, Leticia Garcia-Montoya 1 2, Lynda Bailey 3, Shouvik Dass 1 2, Paul Emery 1 2, Maya H Buch 1 4, Benazir Saleem 3 |
| 125 | |
Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data |
Arthritis Res Ther. 2021 Jan 11;23(1):17. doi: 10.1186/s13075-020-02399-2. |
| 126 | |
Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis |
BMC Musculoskelet Disord. 2021 Jan 8;22(1):47. doi: 10.1186/s12891-020-03917-8. Alison Hammond 1, Yeliz Prior 2, Sarah Cotterill 3, Chris Sutton 3, Elizabeth Camacho 4, Calvin Heal 3, Jo Adams 5, Yvonne Hough 6, Terence W O'Neill 7 8, Jill Firth 9 |
| 127 | |
Thoracic Manifestations of Rheumatoid Arthritis |
Radiographics. Jan-Feb 2021;41(1):32-55. doi: 10.1148/rg.2021200091. Lauren K Groner 1, Daniel B Green 1, Stacey V Weisman 1, Alan C Legasto 1, Dennis Toy 1, James F Gruden 1, Joanna G Escalon 1 |
| 128 | |
Current Management of Trigger Digit in Rheumatoid Arthritis Patients: A Survey of ASSH Members |
Hand (N Y). 2020 Dec 29;1558944720975137. doi: 10.1177/1558944720975137.Online ahead of print. Rebecca Bickham 1, Logan Carr 2, James Butterfield 1, Brittany Behar 3, Ann-Marie Dyer 1, Alexander Payatakes 1 |
| 129 | |
Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses |
BMJ Open. 2020 Dec 31;10(12):e041420. doi: 10.1136/bmjopen-2020-041420. Carlos Alves 1 2, Ana Penedones 2, Diogo Mendes 2, Francisco Batel-Marques 3 2 |
| 130 | |
Statins and lower mortality in rheumatic diseases: An effect of immortal time bias? |
Semin Arthritis Rheum. 2020 Dec 19;51(1):211-218.doi: 10.1016/j.semarthrit.2020.11.010. Online ahead of print. Devin Abrahami 1, Marie Hudson 2, Samy Suissa 3 |
| 131 | |
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities |
Semin Arthritis Rheum. 2020 Dec 17;51(1):219-229.doi: 10.1016/j.semarthrit.2020.11.005. Online ahead of print. Janet E Pope 1, Ernest H Choy 2 |
| 132 | |
The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT |
Rheumatol Int. 2021 Jan 2. doi: 10.1007/s00296-020-04760-9. Online ahead of print. Sean G McKenna 1 2, Alan Donnelly 3 4, Bente Appel Esbensen 5 6, Laura Comber 7, Wan Lin Ng 8, Aqeel Maqsoon Anjum 8, Alexander Fraser 8, Norelee M Kennedy 7 4 |
| 133 | |
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study |
Rheumatology (Oxford). 2020 Dec 25;keaa771. doi: 10.1093/rheumatology/keaa771.Online ahead of print. Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Carlos Areia 9, Patricia Biedermann 10, Juan M Banda 11, Edward Burn 1 4, Paula Casajust 12, Kristina Fister 13, Jill Hardin 2, Laura Hester 2, George Hripcsak 14 15, Benjamin Skov Kaas-Hansen 16 17, Sajan Khosla 18, Spyros Kolovos 1, Kristine E Lynch 19 20, Rupa Makadia 2, Paras P Mehta 21, Daniel R Morales 22, Henry Morgan-Stewart 3, Mees Mosseveld 23, Danielle Newby 24, Fredrik Nyberg 25, Anna Ostropolets 14, Rae Woong Park 26, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Peter Rijnbeek 23, Anthony G Sena 2 23, Azza Shoaibi 2, Matthew Spotnitz 14, Subbian Vignesh 27, Marc A Suchard 28, David Vizcaya 29, Haini Wen 30, Marcel de Wilde 23, Junqing Xie 1, Seng Chan You 26, Lin Zhang 31 32, Simon Lovestone 33, Patrick Ryan 2 14, Daniel Prieto-Alhambra 1, OHDSI-COVID-19 consortium |
| 134 | |
Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis |
Int Immunopharmacol. 2020 Dec 23;91:107260. doi: 10.1016/j.intimp.2020.107260.Online ahead of print. Alison D Petro 1, Joseph Dougherty 2, Bryant R England 3, Harlan Sayles 4, Michael J Duryee 5, Carlos D Hunter 6, Joel M Kremer 7, Dimitrios A Pappas 8, William H Robinson 9, Jeffrey R Curtis 10, Geoffrey M Thiele 11, Ted R Mikuls 12 |
| 135 | |
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis |
Semin Arthritis Rheum. 2020 Dec 17;51(1):15-19.doi: 10.1016/j.semarthrit.2020.09.016. Online ahead of print. Doyt L Conn 1 |
| 136 | |
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease |
Rheumatology (Oxford). 2020 Dec 17;keaa860. doi: 10.1093/rheumatology/keaa860.Online ahead of print. Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 137 | |
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway |
Rheumatology (Oxford)2020 Dec 17;keaa858. doi: 10.1093/rheumatology/keaa858.Online ahead of print. John Fitton 1 2, Andrew R Melville 1 2, Paul Emery 1 2, Jacqueline L Nam 1 2, Maya H Buch 1 3 |
| 138 | |
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience |
Clin Exp Rheumatol. 2020 Dec 18. Online ahead of print. Francesca Romana Spinelli 1, Fulvia Ceccarelli 2, Cristina Garufi 2, Ilaria Duca 2, Silvia Mancuso 2, Enrica Cipriano 2, Elisabetta Dell'Unto 2, Cristiano Alessandri 2, Manuela Di Franco 2, Carlo Perricone 3, Roberta Priori 2, Valeria Riccieri 2, Rossana Scrivo 2, Antonio Sili Scavalli 2, Simona Truglia 2, Guido Valesini 2, Fabrizio Conti 2 |
| 139 | |
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons |
Front Med (Lausanne). 2020 Nov 23;7:601618. doi: 10.3389/fmed.2020.601618.eCollection 2020. Irene Llorente 1, Noelia García-Castañeda 1, Cristina Valero 1, Isidoro González-Álvaro 1, Santos Castañeda 1 2 |
| 140 | |
Rheumatoid arthritis medication adherence in a health system specialty pharmacy |
Am J Manag Care. 2020 Dec 1;26(12):e380-e387. doi: 10.37765/ajmc.2020.88544. Nate Berger 1, Megan Peter, Josh DeClercq, Leena Choi, Autumn D Zuckerman |
| 141 | |
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY |
Rheumatology (Oxford). 2020 Dec 11;keaa770. doi: 10.1093/rheumatology/keaa770.Online ahead of print. Vibeke Strand 1, Namita Tundia 2, Alvin Wells 3, Maya H Buch 4 5, Sebastiao C Radominski 6, Heidi S Camp 7, Alan Friedman 7, Jessica L Suboticki 8, Kendall Dunlap 8, Debbie Goldschmidt 9, Martin Bergman 10 |
| 142 | |
Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study |
J Clin Rheumatol. 2020 Dec 14;Publish Ahead of Print doi:10.1097/RHU.0000000000001616.Online ahead of print. Ingrid Strusberg 1, Eduardo Mysler, Gustavo Citera, Daniel Siri, Maria de Los Ángeles Correa, Maria Alicia Lazaro, Rodolfo Pardo Hidalgo, Alberto Spindler, Patricio Tate, Horacio Venarotti, Jorge Velasco Zamora, Ezequiel Klimovsky, Andrea Federico, Eduardo Scheines, Eliseo Gonzalez, Lucas Cordeiro, Nestor Lago |
| 143 | |
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis |
Rheumatology (Oxford). 2020 Dec 9;keaa557. doi: 10.1093/rheumatology/keaa557.Online ahead of print. Konstantinos Thomas, Argyro Lazarini 1, Evripidis Kaltsonoudis 2, Paraskevi V Voulgari 2, Alexandros A Drosos 2, Argyro Repa 3, Ainour Molla Ismail Sali 3, Prodromos Sidiropoulos 3, Panagiota Tsatsani 4, Sousana Gazi 4, Argyriou Evangelia 5, Kyriaki A Boki 5, Pelagia Katsimbri 1, Dimitrios Boumpas 1, Kalliopi Fragkiadaki 1, Maria G Tektonidou 1, Petros P Sfikakis 1, Konstantina Karagianni 6, Lazaros I Sakkas 6, Eleftheria P Grika 1, Panagiotis G Vlachoyiannopoulos 1, Gerasimos Evangelatos 7, Alexios Iliopoulos 7, Theodoros Dimitroulas 8, Alexandros Garyfallos 8, Konstantinos Melissaropoulos 9, Panagiotis Georgiou 9, Maria Areti 10, Constantinos Georganas 11, Periklis Vounotrypidis 12, Georgios Georgiopoulos 1, George D Kitas 1 13, Dimitrios Vassilopoulos 1 |
| 144 | |
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis |
Nat Rev Rheumatol. 2020 Dec 8. doi: 10.1038/s41584-020-00541-7.Online ahead of print. Maya H Buch 1 2 3, Stephen Eyre 4 5, Dennis McGonagle 6 7 |
| 145 | |
Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19 |
Rheumatol Int.2020 Nov 30;1-10. doi: 10.1007/s00296-020-04751-w. Online ahead of print. Sophia M Brady 1 2 3, Sally A M Fenton 1 2 3, George S Metsios 2 4, Ailsa Bosworth 5, Joan L Duda 1 3, George D Kitas 1 2, Jet J C S Veldhuijzen van Zanten 6 7 8 |
| 146 | |
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients |
Arthritis Res Ther. 2020 Dec 4;22(1):282. doi: 10.1186/s13075-020-02355-0. Jeffrey R Curtis 1, Fenglong Xie 2, Cynthia S Crowson 3, Eric H Sasso 4 5, Elena Hitraya 4 5, Cheryl L Chin 4 5, Richard D Bamford 4 5, Rotem Ben-Shachar 5, Alexander Gutin 5, Darl D Flake 2nd 5, Brent Mabey 5, Jerry S Lanchbury 5 |
| 147 | |
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis |
Rheumatol Ther. 2020 Nov 26. doi: 10.1007/s40744-020-00257-w. Online ahead of print. Christopher J Edwards 1, Ruta Sawant 2, Vishvas Garg 2, Ella X Du 3, Alan Friedman 2, Keith A Betts 4 |
| 148 | |
Update on the diagnosis and management of early rheumatoid arthritis |
Clin Med (Lond). 2020 Nov;20(6):561-564. doi: 10.7861/clinmed.2020-0727. |
| 149 | |
Rheumatoid arthritis and bone health |
Clin Med (Lond). 2020 Nov;20(6):565-567. doi: 10.7861/clinmed.20.6.rabh. |
| 150 | |
Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study |
Rheumatology (Oxford). 2020 Nov 17;keaa576. doi: 10.1093/rheumatology/keaa576.Online ahead of print. Josef S Smolen 1, Li Xie 2, Bochao Jia 2, Peter C Taylor 3, Gerd Burmester 4, Yoshiya Tanaka 5, Ayesha Elias 2, Anabela Cardoso 2, Rob Ortmann 2, Chad Walls 2, Maxime Dougados 6 |
| 151 | |
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double-Blind Trial |
Arthritis Rheumatol. 2020 Nov 18. doi: 10.1002/art.41589. Online ahead of print. Jeffrey R Curtis 1, Paul Emery 2, Elaine Karis 3, Boulos Haraoui 4, Vivian Bykerk 5, Priscilla K Yen 3, Greg Kricorian 3, James B Chung 3 |
| 152 | |
Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up |
Front Med (Lausanne). 2020 Oct 30;7:556086. doi: 10.3389/fmed.2020.556086.eCollection 2020. Marie Robert 1, Arnaud Hot 2, François Mifsud 1, Ndiémé Ndongo-Thiam 1, Pierre Miossec 1 |
| 153 | |
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis |
Ann Rheum Dis. 2020 Nov 4;annrheumdis-2020-218412.doi: 10.1136/annrheumdis-2020-218412. Online ahead of print. Roy M Fleischmann 1, Ricardo Blanco 2, Stephen Hall 3, Glen T D Thomson 4, Filip E Van den Bosch 5 6, Cristiano Zerbini 7, Louis Bessette 8 9, Jeffrey Enejosa 10, Yihan Li 10, Yanna Song 10, Ryan DeMasi 10, In-Ho Song 10 |
| 154 | |
The Role of the Microbiome in Driving RA-Related Autoimmunity |
Front Cell Dev Biol. 2020 Sep 29;8:538130. doi: 10.3389/fcell.2020.538130.eCollection 2020. Cristopher M Rooney 1, Kulveer Mankia 1 2, Paul Emery 1 2 |
| 155 | |
The patient perspective of nurse-led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis |
J Clin Nurs. 2020 Oct 30. doi: 10.1111/jocn.15531. Online ahead of print. Anne-Marie Tetsche Sweeney 1 2, Candy McCabe 1 3 4, Caroline A Flurey 5, Joanna C Robson 1 2, Alice Berry 1 2, Pamela Richards 1 2, Mwidimi Ndosi 1 2 |
| 156 | |
Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study |
BMC Rheumatol. 2020 Oct 21;4:63. doi: 10.1186/s41927-020-00161-4. eCollection 2020. Ian C Scott 1 2, Julie Mount 3, Jane Barry 3, Bruce Kirkham 4 |
| 157 | |
Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort |
Rheumatol Ther. 2020 Oct 28. doi: 10.1007/s40744-020-00247-y. Online ahead of print. John M Davis 3rd 1, Elena Myasoedova 2, Tina M Gunderson 3, Cynthia S Crowson 2 3 |
| 158 | |
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme |
Ann Rheum Dis. 2020 Oct 28;annrheumdis-2020-218510.doi: 10.1136/annrheumdis-2020-218510. Online ahead of print. Stanley B Cohen 1, Ronald F van Vollenhoven 2, Kevin L Winthrop 3, Cristiano A F Zerbini 4, Yoshiya Tanaka 5, Louis Bessette 6, Ying Zhang 7, Nasser Khan 7, Barbara Hendrickson 7, Jeffrey V Enejosa 7, Gerd R Burmester 8 |
| 159 | |
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme |
RMD Open. 2020 Oct;6(3):e001395. doi: 10.1136/rmdopen-2020-001395. Stanley B Cohen 1, Yoshiya Tanaka 2, Xavier Mariette 3, Jeffrey R Curtis 4, Eun Bong Lee 5, Peter Nash 6, Kevin L Winthrop 7, Christina Charles-Schoeman 8, Lisy Wang 9, Connie Chen 10, Kenneth Kwok 10, Pinaki Biswas 10, Andrea Shapiro 11, Ann Madsen 10, Jürgen Wollenhaupt 12 |
| 160 | |
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions |
Peter Hanlon 1, Elaine Butterly 1, Jim Lewsey 1, Stefan Siebert 2, Frances S Mair 1, David A McAllister 3 |
| 161 | |
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib |
Arthritis Res Ther. 2020 Oct 15;22(1):243. doi: 10.1186/s13075-020-02324-7. Vibeke Strand 1, Jeffrey Kaine 2, Rieke Alten 3, Gene Wallenstein 4, Annette Diehl 5, Harry Shi 5, Rebecca Germino 6, Christopher W Murray 7 |
| 162 | |
Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available |
Arthritis Res Ther. 2020 Oct 15;22(1):242. doi: 10.1186/s13075-020-02310-z. Jeffrey R Curtis 1 2 3, Fenglong Xie 4, Hong Zhou 4, David Salchert 4, Huifeng Yun 4 5 |
| 163 | |
Long-term Glucocorticoid Use in Rheumatoid Arthritis |
J Rheumatol. 2020 Oct 15;jrheum.201137. doi: 10.3899/jrheum.201137. Online ahead of print. Maarten Boers 1, Theodore Pincus 1 |
| 164 | |
10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren |
Clin Exp Rheumatol. 2020 Sep 23. Online ahead of print. Rada V Moerman 1, Suzanne Arends 1, Esther Mossel 1, Frans G M Kroese 1, Arjan Vissink 2, Hendrika Bootsma 3 |
| 165 | |
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis |
Adv Ther. 2020 Oct 9. doi: 10.1007/s12325-020-01501-z. Online ahead of print. Stanley B Cohen 1, Jeffrey D Greenberg 2, James Harnett 3, Ann Madsen 4, Timothy W Smith 4, David Gruben 5, Richard Zhang 4, Tatjana Lukic 4, John Woolcott 6, Kimberly J Dandreo 2, Heather J Litman 2, Taylor Blachley 2, Anne Lenihan 7, Connie Chen 4, Jose L Rivas 8, Maxime Dougados 9 10 |
| 166 | |
Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures |
Rheumatol Ther. 2020 Oct 9. doi: 10.1007/s40744-020-00237-0. Online ahead of print. Claire E H Barber 1 2 3, Dianne Mosher 4, Shawn Dowling 4, Victoria Bohm 4, Nathan M Solbak 4, Paul MacMullan 4, Bo Pan 5, Cheryl Barnabe 4 6 7, Glen S Hazlewood 4 6 7, Karen L Then 8, Deborah A Marshall 4 6 7, James A Rankin 8, Linda C Li 7 9, Karen Tsui 10, Kelly English 10, Joanne Homik 11, Nicole Spencer 4, Marc Hall 8, Diane Lacaille 7 12 |
| 167 | |
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis |
Clin Rheumatol. 2020 Oct 11. doi: 10.1007/s10067-020-05402-y. Online ahead of print. Hilde Berner Hammer 1 2, Brigitte Michelsen 3 4, Joe Sexton 3, Till Uhlig 3 5, Sella A Provan 3 |
| 168 | |
EULAR recommendations for a core data set for pregnancy registries in rheumatology |
Ann Rheum Dis. 2020 Oct 14;annrheumdis-2020-218356.doi: 10.1136/annrheumdis-2020-218356. Online ahead of print. Yvette Meissner 1, Rebecca Fischer-Betz 2, Laura Andreoli 3 4, Nathalie Costedoat-Chalumeau 5 6, Diederik De Cock 7, Radboud J E M Dolhain 8, Frauke Forger 9, Doreen Goll 10, Anna Molto 11 12, Catherine Nelson-Piercy 13 14, Rebecca Özdemir 15, Luigi Raio 16, Sebastian Cruz Rodríguez-García 17, Savino Sciascia 18, Marianne Wallenius 19 20, Astrid Zbinden 9, Angela Zink 21, Anja Strangfeld 21 |
| 169 | |
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women |
Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24471. Online ahead of print. Jeffrey R Curtis 1, Michael Weinblatt 2, Kenneth Saag 1, Vivian P Bykerk 3, Daniel E Furst 4 5 6, Stefano Fiore 7, Gregory St John 8, Toshio Kimura 8, Shen Zheng 7, Clifton O Bingham 3rd 9, Grace Wright 10, Martin Bergman 11, Kamala Nola 12, Christina Charles-Schoeman 4, Nancy Shadick 2 |
| 170 | |
Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials |
Nutrients. 2020 Sep 29;12(10):E2991. doi: 10.3390/nu12102991. Josefine Nelson 1, Helen Sjöblom 2, Inger Gjertsson 3, Stine M Ulven 4, Helen M Lindqvist 5, Linnea Bärebring 5 |
| 171 | |
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study |
J Rheumatol. 2020 Oct 1;jrheum.191252. doi: 10.3899/jrheum.191252. Online ahead of print. Anat Fisher 1, Marie Hudson 1, Robert W Platt 1, Colin R Dormuth, Canadian Network for Observational Drug Effect Studies (CNODES) Investigators |
| 172 | |
24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter |
Arthritis Care Res (Hoboken). 2020 Oct 6. doi: 10.1002/acr.24424. Online ahead of print. Lynne M Feehan 1, Na Lu 2, Hui Xie 2, Linda C Li 1 |
| 173 | |
Weight Fluctuation and the Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24469. Online ahead of print. Joshua F Baker 1 2 3, George Reed 4 5, Joel Kremer 6 7 |
| 174 | |
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study |
Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print. Chris A Gentry 1, Mary Beth Humphrey 2 3, Sharanjeet K Thind 4 5, Sage C Hendrickson 1, George Kurdgelashvili 4 5, Riley J Williams 2nd 1 |
| 175 | |
Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry |
ACR Open Rheumatol. 2020 Sep 29.doi: 10.1002/acr2.11168. Online ahead of print. Dimitrios A Pappas 1, Ying Shan 2, Tamara Lesperance 3, Greg Kricorian 4, Elaine Karis 4, Sabrina Rebello 2, Winnie Hua 2, Neil A Accortt 4, Scott Stryker 4 |
| 176 | |
Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies |
Sci Rep. 2020 Sep 29;10(1):16006. doi: 10.1038/s41598-020-71676-6. Tomoya Ohno 1 2, Dagfinn Aune 3 4 5, Alicia K Heath 1 |
| 177 | |
Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades |
Rheumatol Ther. 2020 Sep 30. doi: 10.1007/s40744-020-00238-z.Online ahead of print. Owen Taylor-Williams 1, Johannes Nossent 2 3, Charles A Inderjeeth 4 5 |
| 178 | |
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data |
J Inflamm Res. 2020 Sep 14;13:519-531. doi: 10.2147/JIR.S219586.eCollection 2020. Robert Harrington # 1, Shamma Ahmad Al Nokhatha # 1, Richard Conway 1 |
| 179 | |
A cross-sectional study of sleep and depression in a rheumatoid arthritis population |
Clin Rheumatol. 2020 Sep 24. doi: 10.1007/s10067-020-05414-8. Online ahead of print. Mark Hughes 1, Alan Chalk 2, Poonam Sharma 3, Sandeep Dahiya 3, James Galloway 4 |
| 180 | |
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity |
Rheum Dis Clin North Am. 2020 Nov;46(4):685-692. doi: 10.1016/j.rdc.2020.07.005.Epub 2020 Sep 9. Cheryl Barnabe 1 |
| 181 | |
The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study |
Rheumatol Adv Pract. 2020 Sep 16;4(2):rkaa041. doi: 10.1093/rap/rkaa041. eCollection 2020. James Galloway 1, Jean-Philippe Capron 2, Francesco De Leonardis 3, Walid Fakhouri 4, Alison Rose 5, Ilias Kouris 6, Tom Burke 5 |
| 182 | |
Depression and subsequent risk for incident rheumatoid arthritis among women |
Arthritis Care Res (Hoboken). 2020 Sep 16.doi: 10.1002/acr.24441. Online ahead of print. Jeffrey A Sparks 1 2, Susan Malspeis 1, Jill Hahn 1 2, Jiaqi Wang 1, Andrea L Roberts 3, Laura D Kubzansky 2 3, Karen H Costenbader 1 2 |
| 183 | |
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study |
Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-1594. Online ahead of print. Michael D George 1, Joshua F Baker 2, Kevin Winthrop 3, Jesse Y Hsu 1, Qufei Wu 1, Lang Chen 4, Fenglong Xie 4, Huifeng Yun 4, Jeffrey R Curtis 4 |
| 184 | |
Positive Psychological Factors and Impairment in Rheumatic and Musculoskeletal Disease: Do Psychopathology and Sleep Quality Explain the Linkage? |
Arthritis Care Res (Hoboken). 2020 Sep 16. doi: 10.1002/acr.24440. Online ahead of print. Jameson K Hirsch 1, Heather R Altier 1, Martin Offenbächer 2, Loren Toussaint 3, Niko Kohls 4, Fuschia M Sirois 5 |
| 185 | |
Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: influence of demographic factors |
Joint Bone Spine. 2020 Sep 10;S1297-319X(20)30156-1. doi: 10.1016/j.jbspin.2020.09.003.Online ahead of print. Catia Duarte 1, Eduardo Santos 2, Tore K Kvien 3, Maxime Dougados 4, Maarten de Wit 5, Laure Gossec 6, J A P da Silva 7 |
| 186 | |
Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis |
ACR Open Rheumatol. 2020 Sep 13. doi: 10.1002/acr2.11175. Online ahead of print. Luke W Desilet 1, Bryant R England 1, Kaleb Michaud 2, Jennifer L Barton 3, Ted R Mikuls 1, Joshua F Baker 4 |
| 187 | |
The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial |
Semin Arthritis Rheum. 2020 Jul 30;50(5):1182-1190. doi: 10.1016/j.semarthrit.2020.07.014.Online ahead of print. David Scott 1, Fowzia Ibrahim 2, Harry Hill 3, Brian Tom 4, Louise Prothero 1, Rhiannon R Baggott 1, Ailsa Bosworth 5, James B Galloway 1, Sofia Georgopoulou 1, Naomi Martin 1, Isabel Neatrour 1, Elena Nikiphorou 1, Jackie Sturt 6, Allan Wailoo 3, Frances Mk Williams 7, Ruth Williams 1, Heidi Lempp 1 |
| 188 | |
Reliability and Change in Erosion Measurements by High-Resolution peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis Patients |
J Rheumatol. 2020 Sep 15;jrheum.191391. doi: 10.3899/jrheum.191391. Online ahead of print. Stephanie Finzel 1, Sarah L Manske 1, Cheryl Barnabe 1, Andrew J Burghardt 1, Hubert Marotte 1, Andrea Scharmga 1, Ellen-Margrethe Hauge 1, Roland Chapurlat 1, Klaus Engelke 1, Xiaojuan Li 1, Bente van Teeffelen 1, Philip G Conaghan 1, Kathryn S Stok 1 |
| 189 | |
Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials |
JAMA Netw Open. 2020 Sep 1;3(9):e2013196. doi: 10.1001/jamanetworkopen.2020.13196. Jan Vollert 1 2, Nancy R Cook 1, Ted J Kaptchuk 3, Shiv T Sehra 4, Deirdre K Tobias 1, Kathryn T Hall 1 |
| 190 | |
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study |
Lancet Rheumatol. 2020 Aug 21. doi: 10.1016/S2665-9913(20)30276-9. Online ahead of print. Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Patricia Biedermann 9, Juan M Banda 10, Edward Burn 1 4, Paula Casajust 11, Mitchell M Conover 2, Aedin C Culhane 12, Alexander Davydov 13, Scott L DuVall 14 15, Dmitry Dymshyts 13, Sergio Fernandez-Bertolin 4, Kristina Fišter 16, Jill Hardin 2, Laura Hester 2, George Hripcsak 17 18, Benjamin Skov Kaas-Hansen 19 20, Seamus Kent 21, Sajan Khosla 22, Spyros Kolovos 1, Christophe G Lambert 23, Johan van der Lei 24, Kristine E Lynch 14 15, Rupa Makadia 2, Andrea V Margulis 25, Michael E Matheny 26 27, Paras Mehta 28, Daniel R Morales 29, Henry Morgan-Stewart 3, Mees Mosseveld 24, Danielle Newby 30, Fredrik Nyberg 31, Anna Ostropolets 17, Rae Woong Park 32, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Jenna Reps 2, Peter Rijnbeek 24, Selva Muthu Kumaran Sathappan 33, Martijn Schuemie 2, Sarah Seager 3, Anthony G Sena 2 24, Azza Shoaibi 2, Matthew Spotnitz 17, Marc A Suchard 34, Carmen O Torre 3, David Vizcaya 35, Haini Wen 36, Marcel de Wilde 24, Junqing Xie 1, Seng Chan You 32, Lin Zhang 37 38, Oleg Zhuk 13, </ |
| 191 | |
Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review |
ACR Open Rheumatol. 2020 Sep 1. doi: 10.1002/acr2.11170. Online ahead of print. Christina M Daniel 1, Lesley Davila 1, Una E Makris 2, Helen Mayo 3, Liron Caplan 4, Lisa Davis 5, E Blair Solow 1 |
| 192 | |
Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis |
Medicine (Baltimore). 2020 Aug 28;99(35):e21827. doi: 10.1097/MD.0000000000021827. Jennifer Reams 1, Andrea Berger, Alfred Denio |
| 193 | |
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis |
Ann Rheum Dis. 2020 Aug 28;annrheumdis-2020-217653.doi: 10.1136/annrheumdis-2020-217653. Online ahead of print. Sven Plein 1, Bara Erhayiem 1, Graham Fent 1, Sarah Horton 2, Raluca Bianca Dumitru 3, Jacqueline Andrews 3, John P Greenwood 1, Paul Emery 3 4, |
| 194 | |
Certain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseases |
Clin Rheumatol. 2020 Aug 24. doi: 10.1007/s10067-020-05349-0.Online ahead of print. Sky Wang 1, Richard S Panush 2 |
| 195 | |
Complementary and Alternative Medicine Use in Rheumatoid Arthritis |
Curr Rheumatol Rep. 2020 Aug 26;22(10):61. doi: 10.1007/s11926-020-00938-z. Sara Baig 1, Dana D DiRenzo 2 |
| 196 | |
Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation |
World J Gastrointest Pathophysiol. 2020 Aug 12;11(5):104-113.doi: 10.4291/wjgp.v11.i5.104. Simcha Weissman 1, Preetika Sinh 2, Tej I Mehta 3, Rishi K Thaker 4, Abraham Derman 5, Caleb Heiberger 3, Nabeel Qureshi 1, Viralkumar Amrutiya 1, Adam Atoot 1, Maneesh Dave 6, James H Tabibian 7 |
| 197 | |
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype |
Rheumatology (Oxford). 2020 Aug 18;keaa330. doi: 10.1093/rheumatology/keaa330.Online ahead of print. Karin Hellgren 1, Daniela Di Giuseppe 1, Karin E Smedby 1, Christer Sundström 2, Johan Askling 1, Eva Baecklund 3 |
| 198 | |
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries |
Rheumatology (Oxford). 2020 Aug 18;keaa393. doi: 10.1093/rheumatology/keaa393.Online ahead of print. Delphine S Courvoisier 1, Katarina Chatzidionysiou 2, Denis Mongin 1, Kim Lauper 1 3, Xavier Mariette 4, Jacques Morel 5, Jacques-Eric Gottenberg 6, Sytske Anne Bergstra 7, Manuel Pombo Suarez 8, Catalin Codreanu 9, Tore K Kvien 10, Maria Jose Santos 11, Karel Pavelka 12, Merete L Hetland 13 14, Johan Askling 15, Carl Turesson 16, Satoshi Kubo 17, Yoshiya Tanaka 17, Florenzo Iannone 18, Denis Choquette 19, Dan C Nordström 20, Ziga Rotar 21, Galina Lukina 22, Cem Gabay 1, Ronald Van Vollenhoven 22, Axel Finckh 1 Free article |
| 199 | |
Simple Erosion Narrowing Score of the hands as a predictor of cervical spine subluxation in rheumatoid arthritis |
SA J Radiol. 2020 Jul 27;24(1):1876. doi: 10.4102/sajr.v24i1.1876. eCollection 2020. Eric Gous 1, Mahmood M T M Ally 2, Pieter W A Meyer 3, Farhana E Suleman 1 |
| 200 | |
Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis |
Rheumatol Ther. 2020 Aug 14. doi: 10.1007/s40744-020-00226-3. Online ahead of print. Martin J Bergman 1, Alan J Kivitz 2, Dimitrios A Pappas 3 4, Joel M Kremer 5, Lixia Zhang 6, Anna Jeter 6, Johanna B Withers 7 |
| 201 | |
Enhancing Patient Understanding of Medication Risks and Benefits |
Arthritis Care Res (Hoboken). 2020 Aug 16. doi: 10.1002/acr.24421. Online ahead of print. Susan J Blalock 1, Elizabeth B Solow 2, Valerie F Reyna 3, Molly Keebler 4, Delesha Carpenter 1, Caprice Hunt 1, Genevieve Hickey 1, Kimberlee O'Neill 1, Jeffrey R Curtis 5, Sandra Bond Chapman 4 |
| 202 | |
Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis |
Sci Rep. 2020 Aug 18;10(1):13975. doi: 10.1038/s41598-020-70942-x. J P M Blair 1 2, A-C Bay-Jensen 3, M H Tang 4, P Frederiksen 3, C Bager 4, M Karsdal 3, S Brunak 5 |
| 203 | |
Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits |
Arthritis Care Res (Hoboken). 2020 Aug 19. doi: 10.1002/acr.24429. Online ahead of print. Bryant R England 1, Claire E H Barber 2 3, Martin Bergman 4, Veena K Ranganath 5, Lisa G Suter 6, Kaleb Michaud 1 7 |
| 204 | |
Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI) |
Rheumatology (Oxford). 2020 Aug 13;keaa343. doi: 10.1093/rheumatology/keaa343.Online ahead of print. Janet E Pope 1, Emmanouil Rampakakis 2, Mohammad Movahedi 3 4, Angela Cesta 3, John S Sampalis 2 5, Claire Bombardier 3 6 7 |
| 205 | |
A Serum Protein Signature is associated with Rheumatoid Arthritis development |
Arthritis Rheumatol. 2020 Aug 7. doi: 10.1002/art.41483. Online ahead of print. Liam J O'Neil 1, Victor Spicer 1, Irene Smolik 1, Xiaobo Meng 1, Rishi R Goel 2, Vidyanand Anaparti 1, John Wilkins 1, Hani S El-Gabalawy 1 |
| 206 | |
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis |
Ann Rheum Dis. 2020 Aug 11;annrheumdis-2019-216852.doi: 10.1136/annrheumdis-2019-216852. Online ahead of print. Kevin L Winthrop 1, Masayoshi Harigai 2, Mark C Genovese 3, Stephen Lindsey 4, Tsutomu Takeuchi 5, Roy Fleischmann 6, John D Bradley 7, Nicole L Byers 7, David L Hyslop 7, Maher Issa 7, Atsushi Nishikawa 8, Terence P Rooney 7, Sarah Witt 7, Christina L Dickson 7, Josef S Smolen 9, Maxime Dougados 10 |
| 207 | |
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data |
Ann Rheum Dis. 2020 Aug 5;annrheumdis-2019-216761.doi: 10.1136/annrheumdis-2019-216761. Online ahead of print. Philip Mease 1, Christina Charles-Schoeman 2, Stanley Cohen 3, Lara Fallon 4, John Woolcott 5, Huifeng Yun 6, Joel Kremer 7, Jeffrey Greenberg 8, Wendi Malley 8, Alina Onofrei 8, Keith S Kanik 9, Daniela Graham 9, Cunshan Wang 10, Carol Connell 11, Hernan Valdez 12, Manfred Hauben 13 14, Eric Hung 13, Ann Madsen 15, Thomas V Jones 16, Jeffrey R Curtis 17 |
| 208 | |
Methotrexate Pulmonary Toxicity: Deep Inspirati |
Arthritis Rheumatol. 2020 Jul 27. doi: 10.1002/art.41451. Online ahead of print. Joel M Kremer 1 |
| 209 | |
Vitamin D and early rheumatoid arthritis |
BMC Rheumatol. 2020 Jul 27;4:38. doi: 10.1186/s41927-020-00134-7. eCollection 2020. Stephanie R Harrison 1 2, Gurpreet Jutley 3, Danyang Li 1, Ilfita Sahbudin 3, Andrew Filer 3, Martin Hewison 1 4, Karim Raza 2 3 |
| 210 | |
Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years |
J Rheumatol. 2020 Aug 1;jrheum.200310. doi: 10.3899/jrheum.200310. Online ahead of print. John G Hanly 1, Lynn Lethbridge 1 |
| 211 | |
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis |
Curr Rheumatol Rep. 2020 Aug 1;22(9):56. doi: 10.1007/s11926-020-00933-4. Dilli Poudel 1, Michael D George 1 2, Joshua F Baker 3 4 5 6 |
| 212 | |
Rhupus: a systematic literature review |
Autoimmun Rev. 2020 Jul 12;102612. doi: 10.1016/j.autrev.2020.102612.Online ahead of print. Luca Antonini 1, Brigitte Le Mauff 2, Christian Marcelli 3, Achille Aouba 4, Hubert de Boysson 5 |
| 213 | |
Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women |
J Rheumatol. 2020 Jul 15;jrheum.200056. doi: 10.3899/jrheum.200056. Online ahead of print. Nathalie E Marchand 1, Jeffrey A Sparks 1, Sara K Tedeschi 1, Susan Malspeis 1, Karen H Costenbader 1, Elizabeth W Karlson 1, Bing Lu 1 |
| 214 | |
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases |
Clin Exp Immunol. 2020 Jul 16. doi: 10.1111/cei.13495. Online ahead of print. David Baker 1, Charles Ak Roberts 1, Gareth Pryce 1, Angray S Kang 1 2, Monica Marta 1 3, Saul Reyes 1 3, Klaus Schmierer 1 3, Gavin Giovannoni 1 3, Sandra Amor 1 4 |
| 215 | |
Promoting engagement in physical activity in early rheumatoid arthritis: A proof-of-concept intervention study |
Musculoskeletal Care. 2020 Jul 14. doi: 10.1002/msc.1493. Online ahead of print. Fiona Cramp 1, Rachel Thomas 1, Anne M Haase 1 2 3, Melissa Domaille 1 4, Sarah Manns 1, Caroline Swales 1 5, Judy Hurfurt 1 5, Nicola E Walsh 1 |
| 216 | |
Methotrexate and rheumatoid arthritis associated interstitial lung disease |
Eur Respir J. 2020 Jul 9;2000337. doi: 10.1183/13993003.00337-2020. Online ahead of print. Pierre-Antoine Juge 1 2, Joyce S Lee 3 2, Jessica Lau 4 2, Leticia Kawano-Dourado 5, Jorge Rojas Serrano 6, Marco Sebastiani 7, Gouri Koduri 8, Eric Matteson 9 10, Karina Bonfiglioli 11, Marcio Sawamura 12, Ronaldo Kairalla 5, Lorenzo Cavagna 13, Emanuele Bozzalla Cassione 13, Andreina Manfredi 7, Mayra Mejia 6, Pedro Rodríguez-Henriquez 14, Montserrat I González-Pérez 6, Ramcés Falfán-Valencia 15, Ivette Buendia-Roldán 16, Gloria Pérez-Rubio 15, Esther Ebstein 1, Steven Gazal 17 18, Raphaël Borie 19, Sébastien Ottaviani 1, Caroline Kannengiesser 20, Benoît Wallaert 21, Yurdagul Uzunhan 22, Hilario Nunes 22, Dominique Valeyre 22, Nathalie Saidenberg-Kermanac'h 23, Marie-Christophe Boissier 23, Lidwine Wemeau-Stervinou 21, René-Marc Flipo 24, Sylvain Marchand-Adam 25, Pascal Richette 26 27, Yannick Allanore 28 29, Claire Dromer 30, Marie-Elise Truchetet 31, Christophe Richez 31, Thierry Schaeverbeke 31, Huguette Lioté 32, Gabriel Thabut 33, Kevin D Deane 3, Joshua Solomon 34, Tracy Doyle 35, Jay H Ryu 4, Ivan Rosas 35, V Michael Holers 3, Catherine Boileau 20, Marie-Pierre Debray 36, Raphaël Porcher 37 38, David A Schwartz 3, Robert Vassallo 4, Bruno Crestani 20 2, Philippe Dieudé 39 2 |
| 217 | |
Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients |
Int J Clin Res Trials. 2020;5(1):145. doi: 10.15344/2456-8007/2020/145. Epub 2020 Apr 25. Isabel M McFarlane 1, Manjeet S Bhamra 2, Abhimnayu Amarnani 1, Su Yien Zhaz 3, Srinivas Kolla 4, Milena Rodriguez Alvarez 1, George Mo 1, Maya Srinivasan 1, Gil Hevroni 1 |